Pharsight

Drugs that contain Gadoteridol

1. Prohance patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5474756 BRACCO Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
Dec, 2012

(11 years ago)

US6143274 BRACCO Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
Dec, 2012

(11 years ago)

US5846519 BRACCO Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
Dec, 2015

(8 years ago)

Market Authorisation Date: 16 November, 1992

Treatment: Contrast agent for mri

Dosage: INJECTABLE;INJECTION

More Information on Dosage

PROHANCE family patents

Family Patents

2. Prohance Multipack patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5474756 BRACCO Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
Dec, 2012

(11 years ago)

US6143274 BRACCO Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
Dec, 2012

(11 years ago)

US5846519 BRACCO Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
Dec, 2015

(8 years ago)

Market Authorisation Date: 09 October, 2003

Treatment: Contrast agent for magnetic resonance imaging

Dosage: INJECTABLE;INJECTION

More Information on Dosage

PROHANCE MULTIPACK family patents

Family Patents